Medtronic, Inc.  

(Public, NYSE:MDT)   Watch this stock  
Find more results for Power Balance LLC�
58.05
0.00 (0.00%)
Apr 15 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range     -
52 week 45.39 - 62.90
Open     -
Vol / Avg. 0.00/4.94M
Mkt cap 58.10B
P/E 16.45
Div/yield 0.28/1.93
EPS 3.53
Shares 1.00B
Beta 1.06
Inst. own 80%
May 20, 2014
Q4 2014 Medtronic Inc. Earnings Release - 9:30AM EDT - Add to calendar
May 20, 2014
Q4 2014 Medtronic Inc. Earnings Conference Call Add to calendar
Apr 5, 2014
Investor Briefing from Charing Cross - Webcast
Mar 29, 2014
Medtronic CVG Investor Briefing - Webcast
Mar 12, 2014
Medtronic Inc. at Barclays Healthcare Conference - Webcast
Mar 5, 2014
Medtronic Inc. at Cowen Health Care Conference - Webcast
Feb 24, 2014
Medtronic Inc. at Citi Global Healthcare Conference - Webcast
Feb 18, 2014
Q3 2014 Medtronic Inc. Earnings Release
Feb 18, 2014
Q3 2014 Medtronic Inc. Earnings Conference Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q1 (Jan '14) 2013
Net profit margin 18.30% 20.90%
Operating margin 23.54% 26.53%
EBITD margin - 33.82%
Return on average assets 8.29% 10.25%
Return on average equity 16.04% 19.38%
Employees 46,000 -
CDP Score - 61 D

Address

710 Medtronic Parkway
MINNEAPOLIS, MN 55432-5604
United States - Map
+1-763-5144000 (Phone)
+1-763-5144879 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Medtronic, Inc. (Medtronic) is engaged in medical technology - alleviating pain, restoring health, and extending life for millions of people worldwide. As of April, 27, 2012, the Company functions in two operating segments that manufacture and sells device-based medical therapies. The Company's operating segments include Cardiac and Vascular Group, which consists of Cardiac Rhythm Disease Management (CRDM) and CardioVascular, and Restorative Therapies Group, which consists of Spinal, Neuromodulation, Diabetes and Surgical Technologies. Medtronic serves hospitals, physicians, clinicians, and patients in more than 120 countries worldwide. The Company's primary customers include hospitals, clinics, third-party health care providers, distributors, and other institutions, including governmental health care programs and group purchasing organizations.

Officers and directors

Omar Ishrak Chairman of the Board, Chief Executive Officer
Age: 57
Bio & Compensation  - Reuters
Gary L. Ellis Chief Financial Officer, Senior Vice President
Age: 57
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Michael J. Coyle Executive Vice President, Group President - Cardiac and Vascular Group
Age: 50
Bio & Compensation  - Reuters
Christopher J. O'Connell Executive Vice President and Group President - Restorative Therapies Group
Age: 46
Bio & Compensation  - Reuters
Richard E. Kuntz M.D. Senior Vice President, Chief Scientific, Clinical and Regulatory Officer
Age: 56
Bio & Compensation  - Reuters
Geoffrey S. Martha Senior Vice President - Strategy and Business Development
Age: 43
Bio & Compensation  - Reuters
Catherine M. Szyman Senior Vice President, Group President - Diabetes
Age: 46
Bio & Compensation  - Reuters
Kendall J. Powell Lead Independent Director
Age: 59
Bio & Compensation  - Reuters
Richard H. Anderson Independent Director
Age: 58
Bio & Compensation  - Reuters
Scott C. Donnelly Independent Director
Age: 52
Bio & Compensation  - Reuters